Diagnosed with multiple sclerosis (MS) six years ago and left unable to walk unaided, Numan Unees was facing a challenging future before a pioneering clinical trial gave him new hope.
The 40-year-old is the first patient in Sheffield and the seventh in a global trial to receive an immunotherapy treatment originally developed for some cancers.
Experts said it is still early days, but if this experimental treatment eventually proves to be safe and effective for MS patients it could be a "gamechanger".
Source: BBC News, 3 August 2026
Recommended Comments
Create an account or sign in to comment